[CLDX] YoY Annual Result on 31-Dec-2011 [#FY]

Stock
[CLDX] Celldex Therapeutics, Inc.
Announcement Date
08-Mar-2012
Financial Year
2011
Quarter
31-Dec-2011 [#FY]
Profit Trend
YoY- -1,668.61%
Quarter Report
CLDX's Result
CLDX's Financial Summary
View:
Show?
Annual Result
31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 CAGR
Revenue 3,586 4,111 11,202 9,265 46,793 15,180 7,456 -11.47%
PBT -118,080 -81,550 -59,123 -44,799 -2,533 -37,054 -62,256 11.25%
Tax -4,350 -819 -530 -446 -5,309 -529 27,001 -
NP -118,080 -81,550 -59,123 -44,799 -2,533 -36,525 -47,501 16.38%
Tax Rate - - - - - - - -
Total Cost 121,666 85,661 70,325 54,064 49,326 51,705 54,956 14.15%
Ratio Analysis
31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 CAGR
NP Margin -3,292.81 -1,983.70 -527.79 -483.53 -5.41 -240.61 -637.12 31.47%
Per Share
31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 CAGR
EPS -19.81 -15.33 -15.37 -17.01 -1.19 -27.64 -50.12 -14.32%
EPS Diluted -19.81 -15.33 -15.37 -17.01 -1.19 -27.64 -50.12 -14.32%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.